Alembic Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of September 2025: 0.14%

Alembic Pharmaceuticals Limited (APLLTD) has an Asset Resilience Ratio of 0.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Alembic Pharmaceuticals Limited (APLLTD) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Rs121.50 Million

≈ $1.31 Million USD Cash + Short-term Investments

Total Assets

Rs83.97 Billion

≈ $908.10 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Alembic Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. See net asset quality index of Alembic Pharmaceuticals Limited to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Alembic Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see APLLTD market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs121.50 Million	0.14%
Total Liquid Assets	Rs121.50 Million	0.14%

Asset Resilience Insights

Limited Liquidity: Alembic Pharmaceuticals Limited maintains only 0.14% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Alembic Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare Alembic Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Alembic Pharmaceuticals Limited (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Alembic Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.23%	Rs181.50 Million ≈ $1.96 Million	Rs77.73 Billion ≈ $840.61 Million	-0.19pp
2024-03-31	0.42%	Rs271.30 Million ≈ $2.93 Million	Rs64.46 Billion ≈ $697.07 Million	+0.15pp
2023-03-31	0.27%	Rs166.40 Million ≈ $1.80 Million	Rs61.83 Billion ≈ $668.65 Million	-0.17pp
2022-03-31	0.44%	Rs316.20 Million ≈ $3.42 Million	Rs71.22 Billion ≈ $770.22 Million	-2.34pp
2021-03-31	2.79%	Rs1.87 Billion ≈ $20.22 Million	Rs67.09 Billion ≈ $725.55 Million	-0.34pp
2020-03-31	3.12%	Rs1.87 Billion ≈ $20.22 Million	Rs59.89 Billion ≈ $647.69 Million	+2.93pp
2019-03-31	0.19%	Rs91.00 Million ≈ $984.13K	Rs47.78 Billion ≈ $516.70 Million	-0.12pp
2018-03-31	0.31%	Rs121.80 Million ≈ $1.32 Million	Rs39.41 Billion ≈ $426.21 Million	-1.56pp
2017-03-31	1.87%	Rs503.40 Million ≈ $5.44 Million	Rs26.87 Billion ≈ $290.55 Million	+5.31pp
2016-03-31	-3.44%	Rs-846.16 Million ≈ $-9.15 Million	Rs24.59 Billion ≈ $265.97 Million	--

pp = percentage points

About Alembic Pharmaceuticals Limited

NSE:APLLTD India Drug Manufacturers - Specialty & Generic

Market Cap

$1.59 Billion

Rs147.36 Billion INR

Market Cap Rank

#7135 Global

#338 in India

Share Price

Rs749.70

Change (1 day)

+0.48%

52-Week Range

Rs646.55 - Rs1039.10

All Time High

Rs1247.70